Cited by

• Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.

  Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A. Yadav M, et al. Pediatr Nephrol. 2019 May;34(5):829-835. doi: 10.1007/s00467-018-4071-7. Epub 2018 Sep 7. Pediatr Nephrol. 2019. PMID: 30194663 Clinical Trial.
• Pediatric idiopathic steroid-sensitive nephrotic syndrome: diagnosis and therapy -short version of the updated German best practice guideline (S2e) - AWMF register no. 166-001, 6/2020.

  Ehren R, Benz MR, Brinkkötter PT, Dötsch J, Eberl WR, Gellermann J, Hoyer PF, Jordans I, Kamrath C, Kemper MJ, Latta K, Müller D, Oh J, Tönshoff B, Weber S, Weber LT; German Society for Pediatric Nephrology. Ehren R, et al. Pediatr Nephrol. 2021 Oct;36(10):2971-2985. doi: 10.1007/s00467-021-05135-3. Epub 2021 Jun 6. Pediatr Nephrol. 2021. PMID: 34091756 Free PMC article. Review.
• Corticosteroid therapy for nephrotic syndrome in children.

  Hahn D, Hodson EM, Willis NS, Craig JC. Hahn D, et al. Cochrane Database Syst Rev. 2015 Mar 18;2015(3):CD001533. doi: 10.1002/14651858.CD001533.pub5. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2020 Aug 31;(8):CD001533. doi: 10.1002/14651858.CD001533.pub6. PMID: 25785660 Free PMC article. Updated.
• Chapter 3: Steroid-sensitive nephrotic syndrome in children.

  [No authors listed] [No authors listed] Kidney Int Suppl (2011). 2012 Jun;2(2):163-171. doi: 10.1038/kisup.2012.16. Kidney Int Suppl (2011). 2012. PMID: 25028636 Free PMC article. No abstract available.
• Corticosteroid therapy for nephrotic syndrome in children.

  Hahn D, Samuel SM, Willis NS, Craig JC, Hodson EM. Hahn D, et al. Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD001533. doi: 10.1002/14651858.CD001533.pub7. Cochrane Database Syst Rev. 2024. PMID: 39171624 Free PMC article.